Embera Announces First Subject Dosed in Phase 2a Study of EMB-001
30 Jun 2021 //
BUSINESSWIRE
Embera NeuroTherapeutics Announces First Subject Dosed in Phase 2
31 Aug 2020 //
BUSINESSWIRE
Embera NeuroTherapeutics Completes Series B Financing
19 Dec 2019 //
BUSINESS WIRE